About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
We are dedicated to investigate transfusional activity, the alteration of erythrocytes during the conservation period and extracorporeal photoapheresis. We work on the molecular and serological characterization of blood group variants. In non-invasive fetal genotyping strategies due to blood group incompatibilities. We develop iPSC lines and produce in vitro erythrocytes with rare phenotypes. We deepen in the knowledge of epidemiology and the detection of infectious agents relevant for safety of the products supplied by the Blood and Tissue Bank.
We investigate in clinical immunology and develop our own HLA and KIR typing protocols. We develop and incorporate new therapeutic applications in cell therapy including hematopoietic transplantation, cellular immunology and regenerative medicine. We investigate the molecular mechanisms and genotype-phenotype correlation of coagulopathies, haemorrhagic diathesis and other associated congenital pathologies. We develop tools based on the new technologies of parallel massive sequencing with application to the molecular study, genetic counselling and prenatal diagnosis.
IP: Joaquim Vives Armengol Collaborators: Roberto Vélez Villa, Nayana Joshi Jubert, Lluis Martorell Cedres, Maria Cristina Díaz de Heredia Rubio, Màrius Aguirre Canyadell, Irene Portas Torres, Raquel Cabrera Perez Funding agency: Instituto de Salud Carlos III Funding: 87120 Reference: PI19/01788 Duration: 01/01/2020 - 30/06/2024
IP: Maria Buti Ferret Collaborators: Maria Jose Herrero Mata, Ana Barreira Diaz, Maria del Mar Riveiro Barciela, Jordi Llaneras Artigues, Adriana Palom Agusti Funding agency: Instituto de Salud Carlos III Funding: 117370 Reference: PI20/01692 Duration: 01/01/2021 - 30/06/2025
IP: Nerea Maiz Elizaran Collaborators: Ana Lain Fernandez, Margarita Codinach Creus, Silvia Arévalo Martínez, Pablo García Manau, Paula Garcia Aguilar, Susana Manrique Muñoz, Manuel López Paredes, Ester Del Barco Martínez, Erika Bonacina Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI20/00421 Duration: 01/01/2021 - 30/06/2025
PMID: 37745192 Journal: JHEP Reports Year: 2023 Reference: JHEP Rep. 2023 Jul 13;5(10):100842. doi: 10.1016/j.jhepr.2023.100842. eCollection 2023 Oct. Impact factor: Publication type: Paper in international publication Authors: Berg, Thomas; Bes, Marta; Buti, Maria; Buti, Maria; Casillas, Rosario; Esteban, Rafael; Esteban, Rafael; Palom, Adriana; Pfefferkorn, Maria; Rando-Segura, Ariadna et al. DOI: 10.1016/j.jhepr.2023.100842
PMID: 37767741 Journal: TRANSFUSION Year: 2023 Reference: Transfusion. 2023 Sep 28. doi: 10.1111/trf.17518. Impact factor: Publication type: Paper in international publication Authors: Bes, Marta; Carrio, Jaume; Coco, Sonia Bakkour; Linnen, Jeffrey M; Ong, Edgar; Piron, Maria; Sauleda, Silvia et al. DOI: 10.1111/trf.17518
PMID: 37810253 Journal: iScience Year: 2023 Reference: iScience. 2023 Sep 19;26(10):107948. doi: 10.1016/j.isci.2023.107948. eCollection 2023 Oct 20. Impact factor: Publication type: Paper in international publication Authors: Almirante, Benito; Buzon, Maria Jose; Chafino, Silvia; Fernandez-Veledo, Sonia; Foguet-Romero, Elisabet; Garcia-Pardo, Graciano; Gomez-Bertomeu, Frederic; Lopez-Dupla, Miguel; Olona, Montserrat; Peraire, Joaquim et al. DOI: 10.1016/j.isci.2023.107948
PMID: 37893239 Journal: Biomedicines Year: 2023 Reference: Biomedicines. 2023 Oct 23;11(10):2867. doi: 10.3390/biomedicines11102867. Impact factor: Publication type: Paper in international publication Authors: Aban, M; Abraldes, Juan G; Alegre-Martin, Jose; Alessandria, Carlo; Allegretti, Andrew S; Alonso, Sonia; Andrade, R; Angeli, P; Asrani, Sumeet K; Avitabile, E et al. DOI: 10.3390/biomedicines11102867
PMID: 32135566 Journal: THROMBOSIS AND HAEMOSTASIS Year: 2020 Reference: Thromb Haemost. 2020 Mar;120(3):437-448. doi: 10.1055/s-0040-1702227. Epub 2020 Mar 5. Impact factor: 4.379 Publication type: Paper in international publication Authors: Borras, Nina, Garcia-Martinez, Iris, Batlle, Javier, Perez-Rodriguez, Almudena, Parra, Rafael, Altisent, Carme, Lopez-Fernandez, Maria Fernanda, Costa Pinto, Joana, Batlle-Lopez, Fernando, Cid, Ana Rosa et al. DOI: 10.1055/s-0040-1702227
PMID: 31702113 Journal: HLA Year: 2020 Reference: HLA. 2020 Mar;95(3):179-188. doi: 10.1111/tan.13754. Epub 2019 Nov 25. Impact factor: 2.955 Publication type: Paper in international publication Authors: Herrero, Maria J, Closa, Laia, Vidal, Francisco, Caro, Jose L et al. DOI: 10.1111/tan.13754
PMID: 30444298 Journal: HAEMOPHILIA Year: 2019 Reference: Haemophilia. 2019 Jan;25(1):144-153. doi: 10.1111/hae.13628. Epub 2018 Nov 16. Impact factor: 3.59 Publication type: Paper in international publication Authors: Martinoli, Carlo, Jimenez-Yuste, Victor, Alvarez-Roman, Maria Teresa, Martin-Salces, Monica, De la Corte-Rodriguez, Hortensia, Altisent, Carmen, Parra, Rafael, Nunez, Ramiro, Perez, Rosario, Garcia-Candel, Faustino et al. DOI: 10.1111/hae.13628
PMID: 29448295 Journal: THROMBOSIS AND HAEMOSTASIS Year: 2018 Reference: Thromb Haemost. 2018 Mar;118(3):451-460. doi: 10.1055/s-0038-1624581. Epub 2018 Feb 15. Impact factor: 4.952 Publication type: Paper in international publication Authors: Kessler, Craig, Lassila, Riitta, Nugent, Diane, Oldenburg, Johannes, Garly, May-Lill, Rosholm, Anders, Inbal, Aida, Kerlin, Bryce A, Fukutake, Katsuyuki, Altisent, Carmen et al. DOI: 10.1055/s-0038-1624581
PMID: 27292438 Journal: HAEMOPHILIA Year: 2016 Reference: Haemophilia. 2016 Sep;22(5):739-51. doi: 10.1111/hae.12955. Epub 2016 Jun 13. Impact factor: 2.673 Publication type: Review in international publication Authors: Windyga, J, Dolan, G, Altisent, C, Katsarou, O, Lopez Fernandez, M-F, Zulfikar, B et al. DOI: 10.1111/hae.12955
PMID: 26245874 Journal: THROMBOSIS AND HAEMOSTASIS Year: 2016 Reference: Thromb Haemost. 2016 Jan;115(1):40-50. doi: 10.1160/TH15-04-0282. Epub 2015 Aug 6. Impact factor: 5.255 Publication type: Paper in international publication Authors: Arribalzaga, Karmele, Cabrera, Noelia, Moret, Andres, Parra, Rafael, Mingot-Castellano, Maria Eva, Balda, Ignacia, Altisent, Carmen, Perez-Montes, Rocio, Fisac, Rosa Maria, Iruin, Gemma et al. DOI: 10.1160/TH15-04-0282
